Home > Selling Leads > Febuxostat

Member Since

2008

Shanghai DND Pharm-Technology Co.,Inc.

Febuxostat

Detailed Product Description

Febuxostat, a novel, nonpurine, selective inhibitor of xanthine oxidase, is effective for the treatment of gout and hyperuricemia
It was approved by the european medicines agency on april 21, 2008.
FOB Price:USD6000-6100Shanghai

Cannot find what you're looking for? Post a buying lead.

Send Message